AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2690-4861/303
1 Assistant professor, Department of Neurology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
2 Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
3 School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
*Corresponding Author: Fatemeh Afrashteh, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Citation: Mostafa A. Dooghaee, Imani A., Afrashteh F., (2023), New Onset of Myasthenia Gravis Following COVID-19 Vaccination: A Case Report, International Journal of Clinical Case Reports and Reviews, 13(3); DOI: 10.31579/2690-4861/303
Copyright: © 2023, Fatemeh Afrashteh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 10 March 2023 | Accepted: 24 March 2023 | Published: 31 March 2023
Keywords: sars-cov-2; myasthenia gravis; covid-19 vaccination; neuromuscular junction disorder; guillain-barré syndrome
Myasthenia gravis (MG) is a rare autoimmune disease and the most common neuromuscular junction disorder. The most common symptoms are diplopia, ptosis, and fluctuating weakness of ocular and limb muscles. Here we report a case of MG after COVID-19 vaccination. A 37-year-old Iranian lady presented with generalized weakness, diplopia, and ptosis after three days from taking the second dose of COVID-19 vaccine. Symptoms began three days after taking the second dose of Sinopharm BIBP COVID-19 vaccine (BBIBP-CorV) and worsened within a week. Her past medical history included migraine-type headaches and gastric reflux. She was consuming Rizatriptan and Nortriptyline for her migraine headache and Pantoprazole, Domperidone, and Sertraline for stomach reflux. She had a family history of Essential tremor in her father, uncle, and grandfather. Antibody against the acetylcholine receptor (AChR-Ab) was more than eight times compared to the normal range. The pattern of repetitive nerve stimulation was suggestive for MG. Treatment with corticosteroid, azathioprine, and pyridostigmin led to amelioration of symptoms. Follow-up testing revealed AChR-Ab returned to the normal range.
There are some case reports in that a chronic autoimmune disorder flared up after the COVID1-9 infection or its vaccination. There are several reports of MG exacerbations, acute respiratory distress syndrome, higher ICU admission, and mortality rate and worsening neurological symptoms after COVID-19 infection. There is still debate about the association between neuromuscular disorders and COVID-19 infection and vaccination. This matter is more doubtful for myasthenia gravis.
Myasthenia gravis (MG) is a rare autoimmune disease and the most common neuromuscular. MG is mostly caused by binding autoantibodies to the postsynaptic acetylcholine receptor (AChR) at the neuromuscular junction but other types of antibodies including anti-muscle-specific kinase (anti-MuSK) antibodies may be detected in some cases.[1] The binding of an AChR antibody leads to fluctuating skeletal muscle weakness that gets worse by repetitive contraction, commonly involving ocular, bulbar, respiratory, and proximal limb muscles.
At the emergence of COVID-19 pandemics, the literature pointed toward the point that the developing Sars-Cov-2 infection is related to the increased risk of mortality following hospitalization and severe outcomes in patients with MG.[2] After a while, there have been some reports of a new onset of MG after Sars-Cov-2 infection.[3-5]. It is not known whether this is an association or maybe a causal relationship between Sars-Cov-2 infection and MG.
To the best of our knowledge, there is only one report of a case of COVID-19 Vaccine-associated new-diagnosis Myasthenia Gravis [6].
Here, we report a young lady with a typically generalized myasthenia gravis that the symptoms emerged soon after the second dose of COVID-19 vaccination.
A 37-years-old Iranian lady presented to the neurology clinic with a history of three weeks of diplopia, ptosis, and the weakness of facial and proximal limbs muscles. Symptoms began three days after taking the second dose of Sinopharm BIBP COVID-19 vaccine (BBIBP-CorV) and worsened within a week. She was a Ph.D. student of Health psychology and noticed that the ocular symptoms gradually worsened after studying or working with her laptop. The muscle weakness worsened after walking for several minutes and climbing the stairs. She denied having similar symptoms before. The patient had no history of trauma, thyroid disease, anemia, bladder or bowel dysfunction, or sensory symptoms. She had no respiratory or swallowing complaint, but she noticed that she got tired sooner after walking. Her past medical history included migraine-type headaches and gastric reflux. She was consuming Rizatriptan and Nortriptyline for her migraine headache and Pantoprazole, Domperidone, and Sertraline for stomach reflux. She had a family history of Essential tremor in her father, uncle, and grandfather. Recently, her mother received a diagnosis of Systemic lupus erythematosus (SLE). She had arthralgia and mild leukopenia for several years. Recently, after the third dose of COVID-19 vaccine (AstraZeneca) injection, some skin lesions appeared.
The laboratory tests revealed leukopenia (white blood cells: 3800 *1000/ μL) and increased the titer of anti-nuclear antibody (ANA) and anti-dsDNA.
Neurologic examination revealed asymmetric ptosis, more pronounced on the left side, and was exaggerated after exercise (Figure1). The fore of eye closure was also decreased. Neck flexion and extension and Blowing test were normal. The strength of upper limbs muscles was normal but the Gover’s sign was positive, indicating the weakness of proximal muscles of lower limbs.
According to clinical suspicion of myasthenia gravis, some tests were performed to confirm MG. In addition, some laboratory tests were performed to rule out differential diagnoses including Sars-Cov-2 infection and thyroid disorders. The results are shown in Table1. Routine laboratory factors were normal except for hemoglobin and MHC that were lower than the normal range. The titer of the anti-AChR antibody was 3.3 nmol/L which is more than eight times that normal range. Repetitive nerve stimulation (RNS) was performed and a post-exercise exhaustion response (more than 10
There are several reports of MG exacerbations, acute respiratory distress syndrome, higher ICU admission, and mortality rate and worsening neurological symptoms after COVID-19 infection [7, 8]. Not only the prognosis of COVID-19 infection is more severe in MG patients, but the medications used in COVID-19, such as azithromycin and hydroxychloroquine, also worsen the course of MG disease and taking immunosuppressive drugs due to weakened immune systems in MG patients after COVID-19 infection is still challenging [2].
There are various reports of neurological complications in 78% of COVID-19 infected patients. Encephalopathy, myalgia, seizure, myopathy, optic neuritis, headache, cerebrovascular disease, immune-mediated neuropathy was reported in the course of COVID-19 infection as neurological complications [9].
To the best of our knowledge, this is the second case of new onset MG after the COVID-19 vaccination. In this study, our patient was a 37-year-old lady with a negative history of MG who developed limb and eye muscle weakness, three days after the second dose of BBIBP-CorV vaccine. BBIBP-CorV vaccine is a type of inactivated virus COVID-19 vaccine which was provided by Sinopharm's Beijing Institute of Biological Products. Ancillary tests including AChR antibody and RNS study confirmed the diagnosis of MG. treatment with immunosuppressive and Acetylcholine esterase inhibitors led to amelioration of the symptoms. After six months, clinical remission was achieved and the level of AChR-Ab returned to normal value. In addition, recently her mother was diagnosed to have SLE that its dermatologic manifestations also evolved after injection of third dose of COVID-vaccine.
Recently, an 82-year-old man was reported with intermittent bulbar symptoms after 2 days of injecting the second dose of nucleoside-modified RNA COVID-19 vaccine. The presenting symptoms were intermittent episodes of slurred speech which was more pronounced in the evening. This patient had no ocular symptoms. Clinical suspicion was confirmed with the results of RNS and antibodies titer. The RNS revealed decrementing pattern and the AChR binding Ab, AChR modulating Ab and striational Ab titer were elevated [10].
Besides, a case of MG exacerbations after receiving the Moderna COVID-19 vaccine approximately five and one weeks prior to worsening symptoms has been reported. He was a 77-year-old male with a history of MG and new onset of dysphagia within one week after the COVID-19 vaccination [11]. This could be due to a weak defensive power of T and B lymphocytes because of taking immunosuppressive drugs in these patients, and therefore the COVID-19 vaccination may not be effective in these patients. To treat the patient's symptoms, a low dose of corticosteroids was prescribed to reduce the number of inflammatory cytokines in his body.
Our current knowledge about the consequences of COVID-19 vaccines is limited. One of the neurological consequences of vaccination is Guillain-Barré syndrome (GBS) which has been reported for the first time following two weeks after injection of the Pfizer COVID-19 vaccine in a patient. She was 82-year-old and her symptoms were generalized body pain, paresthesia, and difficulty walking [10]. After that, a GBS onset in a 62-year-old woman after 11 days from Oxford/AstraZeneca COVID-19 vaccine injection with the complaint of paresthesia and progressive weakness of her lower limbs was reported. She received intravenous immunoglobulin (IVIG) at a dose of 2 g/kg for 5 days and but her symptoms worsened and she was admitted to the ICU with mechanical ventilation [12]. Recently, an interesting study compared the incidence of GBS after two types of COVID-19 vaccines including Ad.26.COV2. S (Janssen) and mRNA vaccines. The results showed the risk of GBS for Ad.26.COV2.S (Janssen) vaccines is more than 20 times than mRNA vaccines (adjusted RR= 20.56 (95% CI: 6.94-64.66)) [13].
Because of limited studies, there is still debate about the association between neuromuscular disorders and COVID-19 infection and vaccination (Figure2). This matter is more doubtful for myasthenia gravis. It is not clear if this relationship is just an association or there may be a causal relationship between them. We suppose that the vaccination may induce the immune system, not only for immunization against the virus but also for flare-up the latent autoimmune disorder which had not been unfolded before [14]. One evidence for our claim is that the titer of ACHR-Ab in our patient reached the normal value, six months afterward. Although this may be due to passing time after vaccine-induced autoimmunity, but also the effect of treatment may not be excluded. Another clue is the flare-up of the symptoms in her mother who had the diagnosis of SLE, recently. Her mother was under the supervision of a doctor for arthralgia and leukopenia for several years without any well-known diagnosis. Surprisingly, her lupus was evident after the injection of COVID-19 vaccine and the criteria are fulfilling now. In addition, the positive history for another autoimmune disorder in a family member is a sign of innate susceptibility to an autoimmune disorder.
There are some case reports in that a chronic autoimmune disorder flared up after the COVID1-9 infection or its vaccination. In a study published on 2021 April, 27 subjects had an episode of acute immune-mediated diseases (IMD) after COVID-19 vaccination. Among them, 17 individuals had a flare-up after a well-known IMD and 10 had a new-onset IMD. Interestingly, 21/27 of the patients had a least one previous autoimmune/rheumatic disease diagnosis prior to the vaccination. The authors suggested that the rate of both flares and new-onset IMD after COVID-19 vaccination is rare [14].
One another important issue is the medication choosing, typically immunosuppressive agents for patients with immune-mediated disease including myasthenia gravis. The choice of medication in patients who already have myasthenia gravis and active COVID-19 infection or those who develop MG after infection or vaccination is still controversial.
Figure 2: The immunologic consequences of COVID-19 vaccine
ACHR: acetylcholine receptor
ALP: Alkaline Phosphatase,
ALT: Alanine Aminotransferase
ANA: anti-nuclear antibody
AST: Aspartate Aminotransferase
BBIBP-CorV: Sinopharm BIBP COVID-19 vaccine
BUN: Blood Urea Nitrogen
CPK: Creatinine Phosphokinase
CRP: C-reactive protein
GBS: Guillain-Barré syndrome
HDL: High-Density Lipoprotein
IMD: acute immune-mediated diseases
LDH: Lactate Dehydrogenase
LDL: Low-Density Lipoprotein
MCH: Mean Corpuscular Hemoglobin
MCV: Mean Corpuscular Volume
MG: Myasthenia gravis
MUCK: anti-muscle-specific kinase
R.B.C: Red Blood Cells
RNS: Repetitive nerve stimulation
SI: Serum Iron
SLE: Systemic lupus erythematosus
TIBC: Total Iron-Binding Capacity
TSH: Thyroid Stimulating Hormone
VLDL: Very-Low-Density Lipoprotein
WBC: white blood cells
MA contributed conception and manage the patient. FA contributed writing and data collection. AI contributed writing. All authors contributed to manuscript revision, read and approved the submitted version.
The authors declare that they have no conflict of interest.
Not applicable
Informed consent to participate in this study was given from the patient.
Not applicable
Not applicable
Not applicable
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
